NETWise Episode 46: Understanding Neuroendocrine Carcinoma
Description
In this episode of NETWise, we’re diving into one of the more aggressive forms of neuroendocrine cancer: neuroendocrine carcinoma (NEC). While many neuroendocrine tumors are slow-growing and manageable over time, NEC is different—fast-moving and requiring swift, specialized care.
- We’ll guide you through the essential information about NEC, including:
What neuroendocrine carcinoma is and how it differs from other NETs - The diagnostic process: what to expect and how doctors identify this disease
- Current treatment options and what patients and caregivers should know
If you or a loved one has recently received an NEC diagnosis, this episode is designed to help you start understanding the road ahead.
Resources
Acknowledgements
Dr. Carl Gay, MD, PhD, is a thoracic medical oncologist and research scientist at the University of Texas MD Anderson Cancer Center.
Dr. Aman Chauhan, MD, is a medical oncologist at the Sylvester Comprehensive Cancer Center at the University of Miami, where he leads the neuroendocrine cancer program.
Dr. Renuka Iyer is a medical oncologist at Roswell Park Comprehensive Cancer Center in Buffalo, New York.
Susan Meckler Plummer, RN, runs an online support group for patients with neuroendocrine carcinoma.
Patient Acknowledgements
<div class="elementor-element elementor-element-6870ed1 elementor-widget element
United States
